A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1046-1053

  Moorhead, John W ^a   Clayton, Gerald H ^a   Smith, Roderic L ^a   Schaack, Jerome ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE THERAPY; IMMEDIATE EARLY GENE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION;

ESCHERICHIA COLI;

EID: 0032904969     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1046-1053.1999     Document Type: Article

References (53)

1. Adesanya, M. R., R. S. Redman, B. J. Baum, and B. C. O'Conneli. 1996. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 7:1085-1093.
2. Amalfitano, A., M. A. Hauser, H. Hu, D. Serra, C. R. Begy, and J. S. Chamberlain. 1998. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J. Virol. 72:926-933.
3. Andersson, M., S. Paabo, T. Nilsson, and P. A. Peterson. 1985. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215-222.
4. Asherson, G. L., and W. Ptak. 1968. Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer. Immunology 15:405-416.
5. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
6. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
7. Blair, G. E., S. C. Dixon, S. A. Griffiths, and M. E. Zajdel. 1989. Restricted replication of human adenovirus type 5 in mouse cell lines. Virus Res. 14: 339-346.
8. Blanchard, K. T., and K. Boekelheide. 1997. Adenovirus-mediated gene transfer to rat testis in vivo. Biol. Reprod. 56:495-500.
9. Brough, D. E., A. Lizonova, C. Hsu, V. A. Kulesa, and I. Kovesdi. 1996. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J. Virol. 70:6497-6501.
10. Burgert, H. G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41: 987-997.
11. Burgert, H. G., J. L. Maryanski, and S. Kvist. 1987. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. USA 84:1356-1360.
12. Byrnes, A. P., J. E. Rusby, M. J. Wood, and H. M. Charlton. 1995. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015-1024.
13. Dedieu, J. F., E. Vigne, C. Torrent, C. Jullien, I. Mahfouz, J. M. Caillaud, N. Aubailly, C. Orsini, J. M. Guillaume, P. Opolon, P. Delaere, M. Perricaudet, and P. Yen. 1997. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J. Virol. 71:4626-4637.
14. Elkon, K. B., C. C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. Abrahamsen, X. Song, J. L. Zhou, L. J. Old, R. G. Crystal, and E. Falck-Pedersen. 1997. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 94:9814-9819.
15. Engelhardt. J. F., X. Ye, B. Doranz, and J. M.Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196-6200.
16. Fallaux, F. J., O. Kranenburg, S. J. Cramer, A. Houweling, H. Van Ormondt, R. C. Hoeben, and A. J. Van Der Eb. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
17. Gallin, J. I. 1989. Inflammation, p. 721-733. In W. E. Paul (ed.), Fundamental immunology, 2nd ed. Raven Press, New York, N.Y.
18. Gao, G., Y. Yang, and J. M. Wilson. 1996. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70:8934-8943.
19. Gingras, M. C., P. Arevalo, and E. Aguilar-Cordova. 1996. Potential salmon sperm origin of the E3 region insert of the adenovirus 5 dl309 mutant. Cancer Gene Ther. 3:151-154.
20. Gomez-Foix, A. M., W. S. Coats, S. Baque, T. Alam, R. D. Gerard, and C. B. Newgard. 1992. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 267:25129-25134.
21. Gooding, L. R., and W. S. Wold. 1990. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. Criti. Rev. Immunol. 10: 53-71.
22. Gorziglia, M. I., M. J. Kadan, S. Yei, J. Lim, G. M. Lee, R. Luthra, and B. C. Trapnell. 1996. Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70: 4173-4178.
23. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
24. Grabbe, S., and T. Schwarz. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19:37-44.
25. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 34:59-72.
26. Hay, R. T., A. Freeman, I. Leith, A. Monaghan, and A. Webster. 1995. Molecular interactions during adenovirus DNA replication, p. 31-48. In W. Doerfler and P. Böhm (ed.), Molecular repertoire of adenoviruses II, vol. 199. Springer, Berlin, Germany.
27. Jooss, K., H. C. Ertl, and J. M. Wilson. 1998. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J Virol. 72:2945-2954.
28. Kelly, T. J, Jr. 1984. Adenovirus replication, p. 271-308. In H. S. Ginsberg (ed.), The adenoviruses. Plenum Press, New York, N.Y.
29. Langer, S., and J. Schaack. 1996. Construction of 293 cell lines that inducibly express high levels of precursor terminal protein. Virology 221:172-179.
30. Lei, D., M. Lehmann, J. E. Shellito, S. Nelson, A. Siegling, H. D. Volk, and J. K. Kolls. 1996. Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats. Hum. Gene Ther. 7:2273-2279.
31. Lusky, M., M. Christ, K. Rittner, A. Dieterle, D. Dreyer, B. Mourot, H. Schultz, F. Stoeckel, A. Pavirani, and M. Mehtali. 1998. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J. Virol. 72:2022-2032.
32. Michou, A. I., L. Santoro, M. Christ, V. Julliard, A. Pavirani, and M. Mehtali. 1997. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4:473-482.
33. Morsy, M. A., M. C. Gu, J. Z. Zhao, D. J. Holder, I. T. Rogers, W. J. Pouch, S. L. Motzel, H. J. Klein, S. K. Gupta, X. Liang, M. R. Tota, C. I. Rosenblum, and C. T. Caskey. 1998. Leptin gene therapy and daily protein administration: a comparative study in the ob/ob mouse. Gene Ther. 5:8-18.
34. Muhlhauser, J, M. Jones, I. Yamada, C. Cirielli, P. Lemarchand, T. R. Gloe, B. Bewig, S. Signoretti, R. G. Crystal, and M. C. Capogrossi. 1996. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3:145-153.
35. Phanuphak, P., J. W. Moorhead, and H. C. Claman. 1974. Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J. Immunol. 112:115-123.
36. Raper, S. E., and R. P. DeMatteo. 1996. Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 12:401-410.
37. Rice, S. A., and D. F. Klessig. 1985. Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein. J. Virol. 56:767-778.
38. Robinson, J. H., and J. D. Naysmith. 1976. A comparison of four methods for measuring cutaneous delayed-type hypersensitivity reactions to protein antigens in the mouse. Scand. J. Immunol. 5:299-304.
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
40. Sanes, J. R., J. L. Rubenstein, and J. F. Nicolas. 1986. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:3133-3142.
41. Schaack, J., X. Guo, W. Y.-W. Ho, M. Karlok, C.-Y. Chen, and D. Ornelles. 1995. Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. J. Virol. 69:4079-4085.
42. Schaack, J., X. Guo, and S. Langer. 1996. Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene. Proc. Natl. Acad. Sci. USA 93:14686-14691.
43. Schaack, J., S. Langer, and X. Guo. 1995. Efficient selection of recombinant adenoviruses using vectors that express β-galactosidase. J. Virol. 69:3920-3923.
44. Shenk, T., N. Jones, W. Colby, and D. Fowlkes. 1979. Functional analysis of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harbor Symp. Quant. Biol. 44:367-375.
45. Smith, T. A., M. G. Mehaffey, D. B. Kayda, J. M. Saunders, S. Yei, B. C. Trapnell, A. McClelland, and M. Kaleko. 1993. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5:397-402.
46. Stillman, B. W. 1983. The replication of adenovirus DNA with purified proteins. Cell 35:7-9.
47. Tanaka, Y., and S. S. Tevethia. 1988. Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Db-restricted SV40-specific CTL-mediated lysis. Virology 165:357-366.
48. Van der Vliet, P. C. 1995. Adenovirus DNA replication, p. 1-30. In W. Doerfler and P. Böhm (ed.), The molecular repertoire of adenoviruses II, vol. 199. Springer-Verlag KG, Berlin, Germany.
49. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
50. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.
51. Younghusband, H. B., C. Tyndall, and A. J. Bellett. 1979. Replication and interaction of virus DNA and cellular DNA in mouse cells infected by a human adenovirus. J. Gen. Virol. 45:455-467.
52. Zabner, J., P. Freimuth, A. Puga, A. Fabrega, and M. J. Welsh. 1997. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J. Clin. Investig. 100:1144-1149.
53. Zsengeller, Z. K., G. P. Boivin, S. S. Sawchuk, B. C. Trapnell, J. A. Whitsett, and R. Hirsch. 1997. Anti-T cell receptor antibody prolongs tiansgene expression and reduces lung inflammation after adenovirus-mediated gene transfer. Hum. Gene Ther. 8:935-941.